Regeneron’s Gene Therapy DB-OTO Trial Shows Promising Hearing Improvement
Investigational gene therapy DB-OTO showed promising improvements in hearing and speech development in children with otoferlin-related genetic hearing loss.
Investigational gene therapy DB-OTO showed promising improvements in hearing and speech development in children with otoferlin-related genetic hearing loss.
The Ear Science Institute Australia's project on sensorineural hearing loss treatment will receive research support from MedChem Australia.
Altamira Therapeutics reports that a meta-analysis of nine randomized controlled trials has shown that the oral administration of betahistine, along with the Epley maneuver, is more effective than Epley's maneuver alone.
Merri Rosen, PhD, director of Hearing Research at Northeast Ohio Medical University, has been...
In an article published on the ”Discover Magazine” website, author Sarah Katz challenges the view in the scientific community that deafness is a problem that needs to be cured, potentially by new CRISPR technology that could eliminate a TMC1 gene mutation.
The article mentions the brain changes that studies have shown may happen when hearing loss remains untreated, potentially causing visual and sensory processing centers to access the auditory cortex, which can result in deterioration of the cortex over time.
A new product designed to treat eardrum perforations developed by a Harvard doctoral student, Nicole Black, has just won the “Cure It!” Lemelson-MIT Student Prize.